Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Oculis Holding AG logo

Oculis Holding AG (OCS) Stock Ticker

NASDAQ: OCS · Healthcare · Biotechnology
$9.27-1.49%
USD · as of 2026-09-28 · market cap $530.0M
Open OCS in TickrDownload for iPhone

OCS right now

Options price it to move more than 9 in 10 stocks.
Options expect by Oct 6±12.1%
Options expect by Oct 29±25.0%
Priced in for Nov 5 earnings±27.8%
IV rank (30-day)5% · cheap
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full OCS picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on OCS
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Oculis Holding AG

Oculis Holding AG is a biopharmaceutical company in the clinical development stage, specializing in the creation of innovative eye drop medications for various ocular conditions, addressing both the anterior and posterior segments of the eye. A key asset in its therapeutic portfolio is OCS-01, a topical formulation of dexamethasone, currently progressing through Phase 3 clinical trials for the management of diabetic macular edema. Additionally, OCS-02, a topically administered biological candidate, is engaged in Phase 2b clinical studies to treat keratoconjunctivitis sicca, commonly known as dry eye disease. The company is also advancing OCS-05, an innovative neuroprotective agent, which targets acute optic neuritis and an array of other neuro-ophthalmic disorders, including glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. This enterprise maintains its headquarters in Zug, Switzerland.

OCS stock facts

Ticker symbolOCS
ExchangeNASDAQ Global Market
SectorHealthcare
IndustryBiotechnology
Market cap$530.0M
CEORiad Sherif
Employees60
HeadquartersZug, ZG, CH
IPO date2021-05-18
Websiteoculis.com

What you can see for OCS on Tickr

Live OCS price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the OCS report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Oculis Holding AG?

The ticker symbol for Oculis Holding AG is OCS, listed on the NASDAQ Global Market.

What is OCS?

Oculis Holding AG is a biopharmaceutical company in the clinical development stage, specializing in the creation of innovative eye drop medications for various ocular conditions, addressing both the anterior and posterior segments of the eye. A key asset in its therapeutic portfolio is OCS-01, a topical formulation of dexamethasone, currently progressing through Phase 3 clinical trials for the…

HomeExploreMarketLists
All pages